search-icon
AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Rippling alleges ‘spy’ was paid in Deel espionage case
2
Four Wiz founders surge up global billionaires list with $2.2B each
3
Google’s $32B Wiz deal is just the beginning: Tel Aviv’s startup ecosystem is evolving
4
“Alex told me ‘stay at Rippling and become a spy for Deel’”: Deel CEO’s alleged espionage plot detailed in court
5
Meta’s Israeli development center moving to new Tel Aviv headquarters
More news Buzzmore

Nestlé

3 stories about Nestlé
גלולת הרזיה של אפיטומי

Epitomee surges 200% in two days on FDA approval for weight loss pill

16.09.24|Adiel Eithan Mustaki
Investors are hopeful, but the company must now face an uphill battle in a crowded market.
גלולת הרזיה של אפיטומי

Weight loss pill maker Epitomee’s stock sinks 70% after Nestlé cancels agreement

04.12.23|Adiel Eithan Mustaki
The Swiss conglomerate notified Epitomee that it has decided not to market its product as the clinical trial results measuring the disparity in the weight loss rate between patients who took the pill and the control group did not reach the previously agreed upon success level
default image

A Beloved Israeli Snack Prepares to Take Bigger Bite Out of American Market

07.02.19|Navit Zomer
Generations of Israeli kids grew up eating peanut butter flavored snack Bamba. Now, manufacturer Osem is negotiating a distribution agreement that could make the snack as wildly popular with American kids
ProfilesEngineServlet?at=39&mi=10&pt=18&dpi=1243103233&pai=cTech&dpn=4409&mt=1